Sanofi Dupixent under USFDA priority review for kids with atopic dermatitis Ruchika Sharma11 Feb 2022 12:23 PM ISTParis: Sanofi has recently announced that the U.S. Food and Drug Administration (USFDA) has accepted for Priority Review the supplemental Biologics...
Atopic dermatitis associated to affect mental health Dr. Nandita Mohan3 Feb 2022 4:55 PM ISTAtopic dermatitis affects quality of life greatly, the flares on the skin is much painful and irritating that needs management. Atopic dermatitis is...
2/February/2022 Top Medical Bulletin Dr. Nandita Mohan2 Feb 2022 7:19 PM ISTHere are todays top medical storiesAmerican Academy of Dermatology releases guidelines for Atopic Dermatitis in adults Guidelines in the Journal of...
Difamilast ointment improves Atopic Dermatitis outcomes in juvenile population, finds study Medical Dialogues Editorial Team22 Jan 2022 9:00 AM ISTIn a recent trial, Difamilast 03% and 1% ointments were found to be superior to vehicles and well tolerated in Japanese pediatric patients with Atopic...
Pfizer Cibinqo gets USFDA nod to treat Atopic Dermatitis Ruchika Sharma15 Jan 2022 12:00 PM ISTNew York: Pfizer Inc. has announced that the United States (U.S.) Food and Drug Administration (FDA) has approved CIBINQO (abrocitinib), an oral,...
Atopic dermatitis to be related to higher levels of CRP Dr. Nandita Mohan12 Jan 2022 7:16 PM ISTAtopic Dermatitis (AD) is known to affect 15%-20% of children worldwide. A recent study reported that adults with atopic dermatitis (AD) are at an...
Medical Bulletin 12/January/2022 Dr. Nandita Mohan12 Jan 2022 6:45 PM ISTRaspberries Might Benefit Patients with Hyperglycemia & Dyslipidemia Raspberries are widely consumed for its goodness in vitamins and...
CRP elevated in patients with atopic dermatitis and sleep disorders: Study Medical Dialogues Editorial Team4 Jan 2022 9:00 AM ISTUSA: A recent study reported that adults with atopic dermatitis (AD) are at an increased risk of developing sleep disorders -- which is associated...
FDA approves tralokinumab for moderate-to-severe atopic dermatitis Hina Zahid30 Dec 2021 10:15 PM ISTMADISON, N.J.- The U.S. Food and Drug Administration (FDA) has approved Adbryâ„¢ (tralokinumab-ldrm) for the treatment of moderate-to-severe atopic...
High dose Upadacitinib produces added advantage in moderate to severe atopic dermatitis Hina Zahid13 Dec 2021 9:00 AM ISTUpadacinib is a new drug for the treatment of adults and adolescents aged 12 years and older with moderate to severe atopic dermatitis who are...
Topical tacrolimus as effective as corticosteroids for atopic dermatitis in kids: Study MD Editorial Team3 Dec 2021 9:00 AM ISTFinland: A new study conducted by A. Salava and team noted that the application of tacrolimus 0.03% and 0.1% ointments and topical corticosteroids...
Pre-pregnancy obesity might increase atopic dermatitis risk among infants: Study Dr. Shravani Dali29 Nov 2021 9:00 AM ISTA new investigation from China published in the Pediatric Allergy and Immunology suggested that maternal pre-pregnancy overweight and obesity could...
